UniProt ID | AKAP8_HUMAN | |
---|---|---|
UniProt AC | O43823 | |
Protein Name | A-kinase anchor protein 8 | |
Gene Name | AKAP8 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 692 | |
Subcellular Localization | Nucleus . Nucleus matrix . Nucleus, nucleolus . Cytoplasm . Associated with the nuclear matrix in interphase and redistributes mostly to chromatin at mitosis. However, mitotic chromatin localization has been questioned. Upon nuclear reassembly at the | |
Protein Description | Anchoring protein that mediates the subcellular compartmentation of cAMP-dependent protein kinase (PKA type II). [PubMed: 9473338 Acts as an anchor for a PKA-signaling complex onto mitotic chromosomes, which is required for maintenance of chromosomes in a condensed form throughout mitosis. Recruits condensin complex subunit NCAPD2 to chromosomes required for chromatin condensation; the function appears to be independent from PKA-anchoring] | |
Protein Sequence | MDQGYGGYGAWSAGPANTQGAYGTGVASWQGYENYNYYGAQNTSVTTGATYSYGPASWEAAKANDGGLAAGAPAMHMASYGPEPCTDNSDSLIAKINQRLDMMSKEGGRGGSGGGGEGIQDRESSFRFQPFESYDSRPCLPEHNPYRPSYSYDYEFDLGSDRNGSFGGQYSECRDPARERGSLDGFMRGRGQGRFQDRSNPGTFMRSDPFVPPAASSEPLSTPWNELNYVGGRGLGGPSPSRPPPSLFSQSMAPDYGVMGMQGAGGYDSTMPYGCGRSQPRMRDRDRPKRRGFDRFGPDGTGRKRKQFQLYEEPDTKLARVDSEGDFSENDDAAGDFRSGDEEFKGEDELCDSGRQRGEKEDEDEDVKKRREKQRRRDRTRDRAADRIQFACSVCKFRSFDDEEIQKHLQSKFHKETLRFISTKLPDKTVEFLQEYIVNRNKKIEKRRQELMEKETAKPKPDPFKGIGQEHFFKKIEAAHCLACDMLIPAQPQLLQRHLHSVDHNHNRRLAAEQFKKTSLHVAKSVLNNRHIVKMLEKYLKGEDPFTSETVDPEMEGDDNLGGEDKKETPEEVAADVLAEVITAAVRAVDGEGAPAPESSGEPAEDEGPTDTAEAGSDPQAEQLLEEQVPCGTAHEKGVPKARSEAAEAGNGAETMAAEAESAQTRVAPAPAAADAEVEQTDAESKDAVPTE | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
51 | Phosphorylation | SVTTGATYSYGPASW CCCCCCEEEECCHHH | 10.20 | 80839809 | |
53 | Phosphorylation | TTGATYSYGPASWEA CCCCEEEECCHHHHH | 19.40 | 80839807 | |
79 | Phosphorylation | APAMHMASYGPEPCT CCCCCCHHCCCCCCC | 24.05 | 21945579 | |
80 | Phosphorylation | PAMHMASYGPEPCTD CCCCCHHCCCCCCCC | 27.45 | 21945579 | |
86 | Phosphorylation | SYGPEPCTDNSDSLI HCCCCCCCCCCHHHH | 49.26 | 21945579 | |
89 | Phosphorylation | PEPCTDNSDSLIAKI CCCCCCCCHHHHHHH | 31.24 | 21945579 | |
91 | Phosphorylation | PCTDNSDSLIAKINQ CCCCCCHHHHHHHHH | 22.84 | 21945579 | |
95 | Acetylation | NSDSLIAKINQRLDM CCHHHHHHHHHHHHH | 34.88 | 26051181 | |
95 | Ubiquitination | NSDSLIAKINQRLDM CCHHHHHHHHHHHHH | 34.88 | 29967540 | |
109 | Asymmetric dimethylarginine | MMSKEGGRGGSGGGG HHHCCCCCCCCCCCC | 58.10 | - | |
109 | Methylation | MMSKEGGRGGSGGGG HHHCCCCCCCCCCCC | 58.10 | - | |
112 | Phosphorylation | KEGGRGGSGGGGEGI CCCCCCCCCCCCCCC | 36.77 | 23401153 | |
124 | Phosphorylation | EGIQDRESSFRFQPF CCCCCCCCCCCCCCC | 35.35 | 28555341 | |
136 | Phosphorylation | QPFESYDSRPCLPEH CCCCCCCCCCCCCCC | 29.86 | 11664347 | |
146 | Phosphorylation | CLPEHNPYRPSYSYD CCCCCCCCCCCCCEE | 40.24 | 80839803 | |
149 | Phosphorylation | EHNPYRPSYSYDYEF CCCCCCCCCCEEEEE | 20.08 | 30455651 | |
150 | Phosphorylation | HNPYRPSYSYDYEFD CCCCCCCCCEEEEEE | 17.58 | 30814935 | |
152 | Phosphorylation | PYRPSYSYDYEFDLG CCCCCCCEEEEEECC | 17.82 | 14733435 | |
154 | Phosphorylation | RPSYSYDYEFDLGSD CCCCCEEEEEECCCC | 15.40 | 138797 | |
165 | Phosphorylation | LGSDRNGSFGGQYSE CCCCCCCCCCCCCCC | 25.02 | 82900463 | |
170 | Phosphorylation | NGSFGGQYSECRDPA CCCCCCCCCCCCCHH | 15.09 | 30835193 | |
182 | Phosphorylation | DPARERGSLDGFMRG CHHHHHCCCCHHHCC | 29.52 | 28450419 | |
188 | Methylation | GSLDGFMRGRGQGRF CCCCHHHCCCCCCCC | 29.42 | - | |
190 | Methylation | LDGFMRGRGQGRFQD CCHHHCCCCCCCCCC | 24.73 | - | |
194 | Methylation | MRGRGQGRFQDRSNP HCCCCCCCCCCCCCC | 20.40 | - | |
198 | Methylation | GQGRFQDRSNPGTFM CCCCCCCCCCCCCCC | 27.79 | - | |
199 | Phosphorylation | QGRFQDRSNPGTFMR CCCCCCCCCCCCCCC | 56.52 | 28450419 | |
206 | Ubiquitination | SNPGTFMRSDPFVPP CCCCCCCCCCCCCCC | 33.44 | 24816145 | |
207 | O-linked_Glycosylation | NPGTFMRSDPFVPPA CCCCCCCCCCCCCCC | 37.54 | 30620550 | |
216 | O-linked_Glycosylation | PFVPPAASSEPLSTP CCCCCCCCCCCCCCC | 37.02 | 30620550 | |
217 | O-linked_Glycosylation | FVPPAASSEPLSTPW CCCCCCCCCCCCCCH | 38.21 | 30620550 | |
221 | O-linked_Glycosylation | AASSEPLSTPWNELN CCCCCCCCCCHHHCC | 43.04 | 30620550 | |
222 | O-linked_Glycosylation | ASSEPLSTPWNELNY CCCCCCCCCHHHCCC | 39.75 | 30620550 | |
229 | Phosphorylation | TPWNELNYVGGRGLG CCHHHCCCCCCCCCC | 17.07 | 17360941 | |
232 | Ubiquitination | NELNYVGGRGLGGPS HHCCCCCCCCCCCCC | 15.50 | 24816145 | |
233 | Methylation | ELNYVGGRGLGGPSP HCCCCCCCCCCCCCC | 31.10 | - | |
239 | Phosphorylation | GRGLGGPSPSRPPPS CCCCCCCCCCCCCCC | 38.49 | 26074081 | |
241 | Phosphorylation | GLGGPSPSRPPPSLF CCCCCCCCCCCCCHH | 62.85 | 26074081 | |
242 | Methylation | LGGPSPSRPPPSLFS CCCCCCCCCCCCHHC | 51.64 | - | |
246 | Phosphorylation | SPSRPPPSLFSQSMA CCCCCCCCHHCCCCC | 48.06 | 26074081 | |
249 | Phosphorylation | RPPPSLFSQSMAPDY CCCCCHHCCCCCCCC | 27.00 | 26074081 | |
251 | Phosphorylation | PPSLFSQSMAPDYGV CCCHHCCCCCCCCCC | 18.73 | 26074081 | |
260 | Ubiquitination | APDYGVMGMQGAGGY CCCCCCCCCCCCCCC | 11.67 | 24816145 | |
277 | Methylation | TMPYGCGRSQPRMRD CCCCCCCCCCCCCCC | 35.87 | 24129315 | |
281 | Methylation | GCGRSQPRMRDRDRP CCCCCCCCCCCCCCC | 25.73 | - | |
286 | Ubiquitination | QPRMRDRDRPKRRGF CCCCCCCCCCCCCCC | 75.43 | 24816145 | |
301 | Phosphorylation | DRFGPDGTGRKRKQF CCCCCCCCCCCCCEE | 40.99 | 46161493 | |
306 | Ubiquitination | DGTGRKRKQFQLYEE CCCCCCCCEEEEECC | 59.50 | 24816145 | |
311 | Phosphorylation | KRKQFQLYEEPDTKL CCCEEEEECCCCCCC | 13.89 | 21945579 | |
316 | Phosphorylation | QLYEEPDTKLARVDS EEECCCCCCCEEECC | 38.38 | 21945579 | |
317 | Sumoylation | LYEEPDTKLARVDSE EECCCCCCCEEECCC | 47.75 | 28112733 | |
317 | Ubiquitination | LYEEPDTKLARVDSE EECCCCCCCEEECCC | 47.75 | 29967540 | |
323 | Phosphorylation | TKLARVDSEGDFSEN CCCEEECCCCCCCCC | 40.39 | 29255136 | |
328 | Phosphorylation | VDSEGDFSENDDAAG ECCCCCCCCCCCCCC | 39.98 | 19664994 | |
339 | Phosphorylation | DAAGDFRSGDEEFKG CCCCCCCCCCCCCCC | 51.06 | 29255136 | |
353 | Phosphorylation | GEDELCDSGRQRGEK CCHHCCHHHCCCCCC | 34.57 | 25159151 | |
360 | Ubiquitination | SGRQRGEKEDEDEDV HHCCCCCCCCCHHHH | 73.60 | 24816145 | |
396 | Acetylation | QFACSVCKFRSFDDE HHHHHHCCCCCCCHH | 41.47 | 26051181 | |
399 | Phosphorylation | CSVCKFRSFDDEEIQ HHHCCCCCCCHHHHH | 35.84 | 25159151 | |
407 | Ubiquitination | FDDEEIQKHLQSKFH CCHHHHHHHHHHHHH | 52.52 | 29967540 | |
423 | Phosphorylation | ETLRFISTKLPDKTV HHHHHHHHCCCCHHH | 31.61 | 18551973 | |
424 | Ubiquitination | TLRFISTKLPDKTVE HHHHHHHCCCCHHHH | 51.75 | 29967540 | |
428 | Acetylation | ISTKLPDKTVEFLQE HHHCCCCHHHHHHHH | 53.16 | 26051181 | |
436 | Phosphorylation | TVEFLQEYIVNRNKK HHHHHHHHHHHCHHH | 9.37 | 80839805 | |
465 | Ubiquitination | KPKPDPFKGIGQEHF CCCCCCCCCCCHHHH | 55.81 | 29967540 | |
474 | 2-Hydroxyisobutyrylation | IGQEHFFKKIEAAHC CCHHHHHHHHHHHHH | 52.47 | - | |
517 | Ubiquitination | LAAEQFKKTSLHVAK HHHHHHHHHHHHHHH | 44.63 | 29967540 | |
524 | Ubiquitination | KTSLHVAKSVLNNRH HHHHHHHHHHHCCHH | 39.75 | 29967540 | |
524 | Acetylation | KTSLHVAKSVLNNRH HHHHHHHHHHHCCHH | 39.75 | 25953088 | |
534 | Acetylation | LNNRHIVKMLEKYLK HCCHHHHHHHHHHHC | 36.85 | 20167786 | |
538 | Acetylation | HIVKMLEKYLKGEDP HHHHHHHHHHCCCCC | 52.50 | 19608861 | |
539 | Phosphorylation | IVKMLEKYLKGEDPF HHHHHHHHHCCCCCC | 12.31 | 80839799 | |
567 | Sumoylation | NLGGEDKKETPEEVA CCCCCCCCCCHHHHH | 78.22 | 28112733 | |
569 | Phosphorylation | GGEDKKETPEEVAAD CCCCCCCCHHHHHHH | 44.90 | 27732954 | |
599 | Phosphorylation | EGAPAPESSGEPAED CCCCCCCCCCCCCCC | 42.45 | 22210691 | |
600 | Phosphorylation | GAPAPESSGEPAEDE CCCCCCCCCCCCCCC | 45.58 | 22210691 | |
610 | Phosphorylation | PAEDEGPTDTAEAGS CCCCCCCCCHHHCCC | 57.76 | 30576142 | |
612 | Phosphorylation | EDEGPTDTAEAGSDP CCCCCCCHHHCCCCH | 28.95 | 30576142 | |
617 | Phosphorylation | TDTAEAGSDPQAEQL CCHHHCCCCHHHHHH | 53.84 | 30576142 | |
637 | Acetylation | PCGTAHEKGVPKARS CCCCCCCCCCCHHHH | 56.17 | 26051181 | |
644 | Phosphorylation | KGVPKARSEAAEAGN CCCCHHHHHHHHHCC | 36.13 | 28985074 | |
655 | Phosphorylation | EAGNGAETMAAEAES HHCCCHHHHHHHHHH | 16.15 | 27251275 | |
656 | Sulfoxidation | AGNGAETMAAEAESA HCCCHHHHHHHHHHH | 2.21 | 21406390 | |
662 | Phosphorylation | TMAAEAESAQTRVAP HHHHHHHHHCCCCCC | 32.50 | 27251275 | |
665 | Phosphorylation | AEAESAQTRVAPAPA HHHHHHCCCCCCCCH | 27.16 | 21406692 | |
681 | Phosphorylation | ADAEVEQTDAESKDA HCCHHCCCCHHHCCC | 24.54 | 29255136 | |
685 | Phosphorylation | VEQTDAESKDAVPTE HCCCCHHHCCCCCCC | 37.24 | 29255136 | |
686 | Acetylation | EQTDAESKDAVPTE- CCCCHHHCCCCCCC- | 41.01 | 26051181 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
51 | Y | Phosphorylation | Kinase | LYN | P07948 | PSP |
51 | Y | Phosphorylation | Kinase | SRC | P12931 | PSP |
53 | Y | Phosphorylation | Kinase | LYN | P07948 | PSP |
53 | Y | Phosphorylation | Kinase | SRC | P12931 | PSP |
80 | Y | Phosphorylation | Kinase | SRC | P12931 | PSP |
80 | Y | Phosphorylation | Kinase | LYN | P07948 | PSP |
146 | Y | Phosphorylation | Kinase | LYN | P07948 | PSP |
146 | Y | Phosphorylation | Kinase | SRC | P12931 | PSP |
150 | Y | Phosphorylation | Kinase | SRC | P12931 | PSP |
150 | Y | Phosphorylation | Kinase | LYN | P07948 | PSP |
152 | Y | Phosphorylation | Kinase | LYN | P07948 | PSP |
152 | Y | Phosphorylation | Kinase | SRC | P12931 | PSP |
154 | Y | Phosphorylation | Kinase | LYN | P07948 | PSP |
154 | Y | Phosphorylation | Kinase | SRC | P12931 | PSP |
170 | Y | Phosphorylation | Kinase | SRC | P12931 | PSP |
170 | Y | Phosphorylation | Kinase | LYN | P07948 | PSP |
311 | Y | Phosphorylation | Kinase | LYN | P07948 | PSP |
311 | Y | Phosphorylation | Kinase | SRC | P12931 | PSP |
436 | Y | Phosphorylation | Kinase | LYN | P07948 | PSP |
436 | Y | Phosphorylation | Kinase | SRC | P12931 | PSP |
539 | Y | Phosphorylation | Kinase | SRC | P12931 | PSP |
539 | Y | Phosphorylation | Kinase | LYN | P07948 | PSP |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of AKAP8_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of AKAP8_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
MCM2_HUMAN | MCM2 | physical | 12740381 | |
CCND3_HUMAN | CCND3 | physical | 14641107 | |
CCND1_HUMAN | CCND1 | physical | 14641107 | |
CCND2_HUMAN | CCND2 | physical | 14641107 | |
KAP2_HUMAN | PRKAR2A | physical | 9473338 | |
AMY1_HUMAN | AMY1A | physical | 12414807 | |
DDX5_HUMAN | DDX5 | physical | 11279182 | |
EF1B_HUMAN | EEF1B2 | physical | 26344197 | |
RUVB1_HUMAN | RUVBL1 | physical | 26344197 | |
RUVB2_HUMAN | RUVBL2 | physical | 26344197 | |
TBB4B_HUMAN | TUBB4B | physical | 26344197 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-538, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-323 AND SER-328, ANDMASS SPECTROMETRY. | |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-323 AND SER-328, ANDMASS SPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-323; SER-328 ANDSER-339, AND MASS SPECTROMETRY. | |
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-328, AND MASSSPECTROMETRY. | |
"A probability-based approach for high-throughput proteinphosphorylation analysis and site localization."; Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.; Nat. Biotechnol. 24:1285-1292(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-112, AND MASSSPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-323; SER-328 ANDSER-339, AND MASS SPECTROMETRY. | |
"Large-scale characterization of HeLa cell nuclear phosphoproteins."; Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-328, AND MASSSPECTROMETRY. |